Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal cefuroxime dosing in cirrhotic patients
2013-003349-41Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cefuroxime in Infection, Cirrhosis, hepatic failure and 1 more, sponsored by Erasmus Hospital. Primary endpoint: Pharmacokinetic parameters of cefuroxime. Started Sep 2013; status: completed.
02
Drugs
cefuroxime
03
Conditions
InfectionCirrhosishepatic failurebacterial disease
Beyond the preview
Go deeper on 2013-003349-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003349-41.